Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleMetabolism, Transport, and Pharmacogenomics

Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex

Haoming Zhang, Chitra Sridar, Cesar Kenaan, Hemali Amunugama, David P. Ballou and Paul F. Hollenberg
Journal of Pharmacology and Experimental Therapeutics September 2011, 338 (3) 803-809; DOI: https://doi.org/10.1124/jpet.111.183111
Haoming Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chitra Sridar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cesar Kenaan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hemali Amunugama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David P. Ballou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul F. Hollenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 338 no. 3 803-809
DOI 
https://doi.org/10.1124/jpet.111.183111
PubMed 
21659470

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received April 19, 2011
  • Accepted June 8, 2011
  • Published online August 22, 2011.

Article Versions

  • Earlier version (June 9, 2011 - 08:18).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Haoming Zhang,
  2. Chitra Sridar,
  3. Cesar Kenaan,
  4. Hemali Amunugama,
  5. David P. Ballou and
  6. Paul F. Hollenberg
  1. Departments of Pharmacology (H.Z., C.S., C.K., H.A., P.F.H.) and Biological Chemistry (D.P.B.), University of Michigan, Ann Arbor, Michigan
  1. Address correspondence to:
    Dr. Paul F. Hollenberg, Department of Pharmacology, University of Michigan, 1150 West Medical Center Drive, 2301 MSRB III, Ann Arbor, MI 48109-5632. E-mail: phollen{at}umich.edu.
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2011 to January 2023

AbstractFullPdf
Jun 20114000140
Jul 201160051
Aug 20112211364
Sep 20112191925
Oct 20111062326
Nov 2011851422
Dec 2011401625
Jan 2012381421
Feb 2012701525
Mar 2012481015
Apr 2012471010
May 2012341319
Jun 20123076
Jul 2012191310
Aug 2012321312
Sep 201240820
Oct 2012401716
Nov 201222179
Dec 201271719
Jan 20131121416
Feb 2013252517
Mar 2013311610
Apr 2013241821
May 2013301313
Jun 201315148
Jul 201323814
Aug 201312714
Sep 20134896
Oct 2013211411
Nov 20131266
Dec 201313175
Jan 20141964
Feb 201426168
Mar 20141063
Apr 201417614
May 2014212010
Jun 2014201120
Jul 20143484
Aug 20141395
Sep 201481410
Oct 2014963
Nov 2014923
Dec 201412137
Jan 20151484
Feb 2015952
Mar 2015151415
Apr 20151674
May 2015102611
Jun 2015244
Jul 2015151923
Aug 201571019
Sep 201517158
Oct 2015787
Nov 20158116
Dec 201511123
Jan 20162475
Feb 20161725
Mar 2016211012
Apr 2016958
May 20161568
Jun 201621124
Jul 20162396
Aug 2016154716
Sep 20169108
Oct 201622111
Nov 20163177
Dec 20164213
Jan 20175203
Feb 20173142
Mar 20171256
Apr 20171216
May 201722113
Jun 20173213
Jul 20170132
Aug 20172168
Sep 20172165
Oct 20172224
Nov 201702814
Dec 20177133
Jan 20181140
Feb 20181205
Mar 20181214
Apr 2018112112
May 20180227
Jun 20180334
Jul 20181195
Aug 20180216
Sep 20180226
Oct 20180224
Nov 20181225
Dec 2018922
Jan 20191611
Feb 20192101
Mar 20191665
Apr 2019542
May 20191301
Jun 20191127
Jul 20198212
Aug 201941215
Sep 20192520
Oct 20192410
Nov 20191912
Dec 20193052
Jan 20202520
Feb 2020811
Mar 20201200
Apr 20201201
May 20201330
Jun 20201914
Jul 20202011
Aug 2020301
Sep 20201800
Oct 20202634
Nov 20202212
Dec 20201312
Jan 202116155
Feb 202114216
Mar 20212111
Apr 20212751
May 20213964
Jun 20211570
Jul 20211773
Aug 20211391
Sep 20211130
Oct 20212084
Nov 20212515
Dec 20212122
Jan 20222248
Feb 2022722
Mar 20225311
Apr 20223125
May 20221258
Jun 20224511
Jul 20221821
Aug 20221577
Sep 20222754
Oct 202214111
Nov 20222912
Dec 20223221
Jan 20233593

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 338 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 338, Issue 3
1 Sep 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleMetabolism, Transport, and Pharmacogenomics

Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex

Haoming Zhang, Chitra Sridar, Cesar Kenaan, Hemali Amunugama, David P. Ballou and Paul F. Hollenberg
Journal of Pharmacology and Experimental Therapeutics September 1, 2011, 338 (3) 803-809; DOI: https://doi.org/10.1124/jpet.111.183111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleMetabolism, Transport, and Pharmacogenomics

Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex

Haoming Zhang, Chitra Sridar, Cesar Kenaan, Hemali Amunugama, David P. Ballou and Paul F. Hollenberg
Journal of Pharmacology and Experimental Therapeutics September 1, 2011, 338 (3) 803-809; DOI: https://doi.org/10.1124/jpet.111.183111
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • HDL Mimetic 4F Modulates Aβ Distribution in Brain and Plasma
  • AOX1 Inhibition by Gefitinib, Erlotinib, and Metabolites
  • Catalytic Activity of CYP2C9 Variants
Show more Metabolism, Transport, and Pharmacogenomics

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics